Dysregulation of the expression of individual annexins has been associated with breast cancer development and poor prognosis, and modulation of calcium signaling by p53 has been associated with lack of sensitivity to chemotherapy and radiotherapy [20, 22, 27, 45–49]. This evidence concerns the gene TP53 and breast cancer.